StockData
IMMUTEP Ltd logo

IMMUTEP Ltd (IMMP) stock

IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 23, 2026Score 8/30
$3.26−0.14 (-4.12%)

Close on Nov 17, 2026Market cap $24.02MP/E –Yield –

Immutep price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Immutep's price to sales ratio was 1.6× on Nov 11, 2026, against 43.7× a year earlier. Over the last 5 years it ranged from 1.3× to 77.0×, with a median of 44.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.6×−58.9
2025Dec 31, 202560.4×+6.7
2024Dec 31, 202453.8×−6.6
2023Dec 29, 202360.3×+28.0
2022Dec 30, 202232.3×−35.4
2021Dec 31, 202167.7×+57.5
2020Dec 31, 202010.2×−1.6
2019Dec 31, 201911.8×+2.0
2018Dec 31, 20189.8×−2.1
2017Dec 29, 201711.9×−25.5
2016Dec 30, 201637.4×–

More Immutep figures

See a number that looks wrong?